Literature DB >> 29296718

Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α.

Beatrice Macchi1, Emanuela Balestrieri2, Caterina Frezza1,3, Sandro Grelli2, Elena Valletta1, Ambroise Marçais4,5,6, Francesca Marino-Merlo7, Jocelyn Turpin8, Charles R Bangham8, Olivier Hermine4,5,6, Antonio Mastino3,9, Ali Bazarbachi10,11.   

Abstract

The therapeutic efficacy of the AZT and IFN combination in ATL presumably reflects the inhibition of RT-related functions.HTLV-1-RT activity from short-term cultured PBMCs may represent a predictive correlate of clinical response to AZT/IFN in ATL patients.

Entities:  

Year:  2017        PMID: 29296718      PMCID: PMC5728049          DOI: 10.1182/bloodadvances.2016001370

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  22 in total

1.  Antiviral activity of seed extract from Citrus bergamia towards human retroviruses.

Authors:  Emanuela Balestrieri; Francesco Pizzimenti; Angelo Ferlazzo; Salvatore V Giofrè; Daniela Iannazzo; Anna Piperno; Roberto Romeo; Maria Assunta Chiacchio; Antonio Mastino; Beatrice Macchi
Journal:  Bioorg Med Chem       Date:  2011-01-26       Impact factor: 3.641

2.  Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.

Authors:  O Hermine; D Bouscary; A Gessain; P Turlure; V Leblond; N Franck; A Buzyn-Veil; B Rio; E Macintyre; F Dreyfus
Journal:  N Engl J Med       Date:  1995-06-29       Impact factor: 91.245

3.  Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.

Authors:  Renata Okajima; Jorge Casseb; José A Sanches
Journal:  Int J Dermatol       Date:  2013-01       Impact factor: 2.736

4.  The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.

Authors:  Nicolas A Gillet; Nirav Malani; Anat Melamed; Niall Gormley; Richard Carter; David Bentley; Charles Berry; Frederic D Bushman; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

5.  AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.

Authors:  B Macchi; I Faraoni; J Zhang; S Grelli; C Favalli; A Mastino; E Bonmassar
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

6.  Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.

Authors:  Emanuela Balestrieri; Claudia Matteucci; Arianna Ascolani; Anna Piperno; Roberto Romeo; Giovanni Romeo; Ugo Chiacchio; Antonio Mastino; Beatrice Macchi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

7.  Phosphonated carbocyclic 2'-oxa-3'-azanucleosides as new antiretroviral agents.

Authors:  Ugo Chiacchio; Antonio Rescifina; Daniela Iannazzo; Anna Piperno; Roberto Romeo; Luisa Borrello; Maria Teresa Sciortino; Emanuela Balestrieri; Beatrice Macchi; Antonio Mastino; Giovanni Romeo
Journal:  J Med Chem       Date:  2007-06-20       Impact factor: 7.446

Review 8.  Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.

Authors:  A Bazarbachi; O Hermine
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

9.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

10.  T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.

Authors:  Aileen G Rowan; Aviva Witkover; Anat Melamed; Yuetsu Tanaka; Lucy B M Cook; Paul Fields; Graham P Taylor; Charles R M Bangham
Journal:  PLoS Pathog       Date:  2016-11-28       Impact factor: 6.823

View more
  13 in total

1.  Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells.

Authors:  Claudia Matteucci; Francesca Marino-Merlo; Antonella Minutolo; Emanuela Balestrieri; Elena Valletta; Beatrice Macchi; Antonio Mastino; Sandro Grelli
Journal:  Cell Death Discov       Date:  2020-02-18

2.  Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.

Authors:  Emi Ikebe; Sahoko Matsuoka; Kenta Tezuka; Madoka Kuramitsu; Kazu Okuma; Makoto Nakashima; Seiichiro Kobayashi; Junya Makiyama; Makoto Yamagishi; Seiichi Oyadomari; Kaoru Uchimaru; Isao Hamaguchi
Journal:  Blood Adv       Date:  2020-05-12

Review 3.  Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.

Authors:  Rita Hleihel; Abdou Akkouche; Hala Skayneh; Olivier Hermine; Ali Bazarbachi; Hiba El Hajj
Journal:  Curr Oncol Rep       Date:  2021-11-04       Impact factor: 5.075

4.  The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.

Authors:  Simin D Rezaei; Hao K Lu; J Judy Chang; Ajantha Rhodes; Sharon R Lewin; Paul U Cameron
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

5.  Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Authors:  Lucy B Cook; Shigeo Fuji; Olivier Hermine; Ali Bazarbachi; Juan Carlos Ramos; Lee Ratner; Steve Horwitz; Paul Fields; Alina Tanase; Horia Bumbea; Kate Cwynarski; Graham Taylor; Thomas A Waldmann; Achilea Bittencourt; Ambroise Marcais; Felipe Suarez; David Sibon; Adrienne Phillips; Matthew Lunning; Reza Farid; Yoshitaka Imaizumi; Ilseung Choi; Takashi Ishida; Kenji Ishitsuka; Takuya Fukushima; Kaoru Uchimaru; Akifumi Takaori-Kondo; Yoshiki Tokura; Atae Utsunomiya; Masao Matsuoka; Kunihiro Tsukasaki; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2019-01-18       Impact factor: 44.544

Review 6.  Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview.

Authors:  Francesca Marino-Merlo; Emanuela Balestrieri; Claudia Matteucci; Antonio Mastino; Sandro Grelli; Beatrice Macchi
Journal:  Pathogens       Date:  2020-05-01

7.  Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells.

Authors:  Claudia Matteucci; Francesca Marino-Merlo; Antonella Minutolo; Emanuela Balestrieri; Elena Valletta; Beatrice Macchi; Antonio Mastino; Sandro Grelli
Journal:  Cell Death Discov       Date:  2020-02-18

8.  Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients.

Authors:  Beatrice Macchi; Caterina Frezza; Francesca Marino-Merlo; Antonella Minutolo; Valeria Stefanizzi; Emanuela Balestrieri; Carlotta Cerva; Loredana Sarmati; Massimo Andreoni; Sandro Grelli; Antonio Mastino
Journal:  Pathogens       Date:  2020-12-13

Review 9.  Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma.

Authors:  Francesca Marino-Merlo; Antonio Mastino; Sandro Grelli; Olivier Hermine; Ali Bazarbachi; Beatrice Macchi
Journal:  Front Microbiol       Date:  2018-05-09       Impact factor: 5.640

Review 10.  Novel Treatments of Adult T Cell Leukemia Lymphoma.

Authors:  Hiba El Hajj; Kunihiro Tsukasaki; Morgane Cheminant; Ali Bazarbachi; Toshiki Watanabe; Olivier Hermine
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.